RNR catalyzes the rate-limiting step in dNTP synthesis and is a well-recognized target for cancer therapy; however, the biological role of RRM1, the main catalytic subunit of RNR, in SCLC remains unclear. This evidence concerns the gene NR2E3 and small cell lung carcinoma.